Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Dandan Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Lipid Metabolism, Nuclear Receptor Subfamily 1, Group D, Member 1, Podocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xuzhou Science and Technology Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University,…
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China; Public Experimental Research Center of Xuzhou Medical University, Xuzhou Medical Universi…
- Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China.
- Department of Pathophysiology, Shenzhen University, Shenzhen 518060, China; Shenzhen University Health Science Center, Shenzhen University, Shenzhen 518060, China.
- State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China; State Key Laboratory of Vascular Homeostasis and Remodeling, Departm…
Förderung
- Xuzhou Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Zhong, D., Chen, J., Qiao, R., Song, C., Hao, C., Zou, Y., Bai, M., Su, W., Yang, B., Sun, D., Jia, Z., & Sun, Y. (2024). Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114075
Vancouver
Zhong D, Chen J, Qiao R, Song C, Hao C, Zou Y, et al. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114075
BibTeX
@article{Zhong2024,
author = {Zhong, Dandan and Chen, Jingshuo and Qiao, Ranran and Song, Chang and Hao, Chang and Zou, Yingying and Bai, Mi and Su, Wen and Yang, Baoxue and Sun, Dong and Jia, Zhanjun and Sun, Ying},
title = {Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114075}
}
EUVIMED